BRAF and metastatic neoplasm: In predicting DFS, factors such as the number of metastatic tumors, cN stage, KRAS and BRAF mutations, patient age, primary tumor site, CEA levels, neutrophil count, monocyte count, platelet count, and D-Dimer levels were identified as significant predictors for DFS using univariate analysis.